Kinetosis Drugs Market Insights, Global Outlook and Forecast 2022-2028
Kinetosis Drugs Market Insights, Global Outlook and Forecast 2022-2028
Get latest Market Research Reports on Kinetosis Drugs. Industry analysis and Market Report on Kinetosis Drugs is a syndicated market report, published as Global Kinetosis Drugs Market Research Report . It is complete Research Study and Industry Analysis of Kinetosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The latest research study released by Market IntelliX evaluates market size and forecasts of Kinetosis Drugs in global, including the following market information:
Global Kinetosis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Kinetosis Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Kinetosis Drugs companies in 2021 (%)
The global Kinetosis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anticholinergic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Kinetosis Drugs include GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Mylan, Sandoz, Pfizer, Myungmoon Pharm and Caleb Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Kinetosis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Kinetosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Kinetosis Drugs Market Segment Percentages, by Type, 2021 (%)
Anticholinergic
Antihistamines
Others
Global Kinetosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Kinetosis Drugs Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Global Kinetosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Kinetosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kinetosis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Kinetosis Drugs revenues share in global market, 2021 (%)
Key companies Kinetosis Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Kinetosis Drugs sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Mylan
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Kinetosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kinetosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kinetosis Drugs Overall Market Size
2.1 Global Kinetosis Drugs Market Size: 2021 VS 2028
2.2 Global Kinetosis Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Kinetosis Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Kinetosis Drugs Players in Global Market
3.2 Top Global Kinetosis Drugs Companies Ranked by Revenue
3.3 Global Kinetosis Drugs Revenue by Companies
3.4 Global Kinetosis Drugs Sales by Companies
3.5 Global Kinetosis Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Kinetosis Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Kinetosis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kinetosis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Kinetosis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Kinetosis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Kinetosis Drugs Market Size Markets, 2021 & 2028
4.1.2 Anticholinergic
4.1.3 Antihistamines
4.1.4 Others
4.2 By Type - Global Kinetosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Kinetosis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Kinetosis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Kinetosis Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Kinetosis Drugs Sales & Forecasts
4.3.1 By Type - Global Kinetosis Drugs Sales, 2017-2022
4.3.2 By Type - Global Kinetosis Drugs Sales, 2023-2028
4.3.3 By Type - Global Kinetosis Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Kinetosis Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Kinetosis Drugs Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Kinetosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Kinetosis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Kinetosis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Kinetosis Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Kinetosis Drugs Sales & Forecasts
5.3.1 By Application - Global Kinetosis Drugs Sales, 2017-2022
5.3.2 By Application - Global Kinetosis Drugs Sales, 2023-2028
5.3.3 By Application - Global Kinetosis Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Kinetosis Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Kinetosis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Kinetosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Kinetosis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Kinetosis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Kinetosis Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Kinetosis Drugs Sales & Forecasts
6.3.1 By Region - Global Kinetosis Drugs Sales, 2017-2022
6.3.2 By Region - Global Kinetosis Drugs Sales, 2023-2028
6.3.3 By Region - Global Kinetosis Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Kinetosis Drugs Revenue, 2017-2028
6.4.2 By Country - North America Kinetosis Drugs Sales, 2017-2028
6.4.3 US Kinetosis Drugs Market Size, 2017-2028
6.4.4 Canada Kinetosis Drugs Market Size, 2017-2028
6.4.5 Mexico Kinetosis Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Kinetosis Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Kinetosis Drugs Sales, 2017-2028
6.5.3 Germany Kinetosis Drugs Market Size, 2017-2028
6.5.4 France Kinetosis Drugs Market Size, 2017-2028
6.5.5 U.K. Kinetosis Drugs Market Size, 2017-2028
6.5.6 Italy Kinetosis Drugs Market Size, 2017-2028
6.5.7 Russia Kinetosis Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Kinetosis Drugs Market Size, 2017-2028
6.5.9 Benelux Kinetosis Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Kinetosis Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Kinetosis Drugs Sales, 2017-2028
6.6.3 China Kinetosis Drugs Market Size, 2017-2028
6.6.4 Japan Kinetosis Drugs Market Size, 2017-2028
6.6.5 South Korea Kinetosis Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Kinetosis Drugs Market Size, 2017-2028
6.6.7 India Kinetosis Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Kinetosis Drugs Revenue, 2017-2028
6.7.2 By Country - South America Kinetosis Drugs Sales, 2017-2028
6.7.3 Brazil Kinetosis Drugs Market Size, 2017-2028
6.7.4 Argentina Kinetosis Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Kinetosis Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Kinetosis Drugs Sales, 2017-2028
6.8.3 Turkey Kinetosis Drugs Market Size, 2017-2028
6.8.4 Israel Kinetosis Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Kinetosis Drugs Market Size, 2017-2028
6.8.6 UAE Kinetosis Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Kinetosis Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Prestige Brands
7.2.1 Prestige Brands Corporate Summary
7.2.2 Prestige Brands Business Overview
7.2.3 Prestige Brands Kinetosis Drugs Major Product Offerings
7.2.4 Prestige Brands Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Prestige Brands Key News
7.3 WellSpring Pharmaceutical Corporation
7.3.1 WellSpring Pharmaceutical Corporation Corporate Summary
7.3.2 WellSpring Pharmaceutical Corporation Business Overview
7.3.3 WellSpring Pharmaceutical Corporation Kinetosis Drugs Major Product Offerings
7.3.4 WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.3.5 WellSpring Pharmaceutical Corporation Key News
7.4 Baxter International
7.4.1 Baxter International Corporate Summary
7.4.2 Baxter International Business Overview
7.4.3 Baxter International Kinetosis Drugs Major Product Offerings
7.4.4 Baxter International Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Baxter International Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Kinetosis Drugs Major Product Offerings
7.5.4 Mylan Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Mylan Key News
7.6 Sandoz
7.6.1 Sandoz Corporate Summary
7.6.2 Sandoz Business Overview
7.6.3 Sandoz Kinetosis Drugs Major Product Offerings
7.6.4 Sandoz Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Sandoz Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Kinetosis Drugs Major Product Offerings
7.7.4 Pfizer Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 Myungmoon Pharm
7.8.1 Myungmoon Pharm Corporate Summary
7.8.2 Myungmoon Pharm Business Overview
7.8.3 Myungmoon Pharm Kinetosis Drugs Major Product Offerings
7.8.4 Myungmoon Pharm Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Myungmoon Pharm Key News
7.9 Caleb Pharmaceuticals
7.9.1 Caleb Pharmaceuticals Corporate Summary
7.9.2 Caleb Pharmaceuticals Business Overview
7.9.3 Caleb Pharmaceuticals Kinetosis Drugs Major Product Offerings
7.9.4 Caleb Pharmaceuticals Kinetosis Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Caleb Pharmaceuticals Key News
8 Global Kinetosis Drugs Production Capacity, Analysis
8.1 Global Kinetosis Drugs Production Capacity, 2017-2028
8.2 Kinetosis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kinetosis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kinetosis Drugs Supply Chain Analysis
10.1 Kinetosis Drugs Industry Value Chain
10.2 Kinetosis Drugs Upstream Market
10.3 Kinetosis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kinetosis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Kinetosis Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|